AQR Arbitrage’s Trillium Therapeutics Inc. TRIL Stock Holding History

AQR Arbitrage’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,393,859	Closed	-$24.5M	–	1478
2021 Q3	$24.5M	Buy	+1,393,859	New	+$16.3M	0.7%	34

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

AQR Arbitrage's TRIL Position: Q4 2021 in Review

AQR Arbitrage sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 1,393,859 shares — an estimated $24.5M sold.

AQR Arbitrage first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $24.5M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

AQR Arbitrage reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
AQR Arbitrage sold 1,393,859 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $24.5M.
AQR Arbitrage first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
AQR Arbitrage's Trillium Therapeutics Inc. position peaked at $24.5M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on AQR Arbitrage's 13F filing for Q4 2021, filed 14 Feb 2022.